|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced. |
|||||||||||||||||||||||||||||||||||||||||||||||||
Download
|
|
pCase12-mito is a mammalian expression vector encoding mitochondria-targeted fluorescent Ca2+ sensor Case12 (see reporter description). Case12 codon usage is optimized for high expression in mammalian cells (humanized) [Haas et al., 1996]. Mitochondrial targeting sequence (MTS) is fused to the Case12 N-terminus. MTS was derived from the subunit VIII of human cytochrome C oxidase [Rizzuto et al., 1989; Rizzuto et al., 1995].
HeLa cell expressing fluorescent Ca2+ sensor Case12 targeted to mitochondria. |
pCase12-mito vector can be used as a source of MTS-Case12 hybrid sequence. The vector backbone contains unique restriction sites that permit its excision and further insertion into expression vector of choice. Alternatively, MTS-Case12 coding sequence can be amplified by PCR.
Note: The plasmid DNA was isolated from dam+-methylated
The vector backbone contains immediate early promoter of cytomegalovirus (PCMV IE) for protein expression, SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in
SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in
Expression in mammalian cells
pCase12-mito vector can be transfected into mammalian cells by any known transfection method. CMV promoter provides strong, constitutive Case12 expression in eukaryotic cells. If required, stable transformants can be selected using G418 [Gorman, 1985].
Propagation in
Suitable host strains for propagation in
Location of features
PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
Case12-Mito fusion
Start codon (ATG): 597-599
Mitochondrial localization signal (MLS): 597-683
Start of Case12 coding sequence (ATG): 705-707
Stop codon: 1950-1952
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1948-1953, 2106-2111 & 2135-2140
mRNA 3' ends: 2144 & 2156
f1 single-strand DNA origin: 2203-2658
Bacterial promoter for expression of Kanr gene
-35 region: 2720-2725
-10 region: 2743-2748
Transcription start point: 2755
SV40 origin of replication: 2999-3134
SV40 early promoter
Enhancer (72-bp tandem repeats): 2832-2903 & 2904-2975
21-bp repeats: 2979-2999, 3000-3020 & 3022-3042
Early promoter element: 3055-3061
Major transcription start points: 3051, 3089, 3095 & 3100
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 3183-3185
Stop codon: 3975-3977
G->A mutation to remove Pst I site: 3365
C->A (Arg to Ser) mutation to remove BssH II site: 3711
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 4213-4218 & 4226-4231
pUC plasmid replication origin: 4562-5205
Case12-related materials (also referred to as "Products") are intended for research use only. Some elements of these materials may be covered by third party patents issued and applicable in certain countries. No license under these patents is conveyed expressly or by implication to the recipient of the materials. Users of these materials may be required to obtain a patent license depending upon the particular application and country in which the materials are received or used.
Copyright 2002-2023 Evrogen. All rights reserved. Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, Tel +7(495)988-4084, Fax +7(495)988-4085, e-mail:evrogen@evrogen.com |